0 items USD 0.00Search
Your search for "mrrpb5 global biosimilars treatment market size status forecast 2019 2025" gave back 35924 results.
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
Clinical diagnoses of rheumatoid arthritis has seen a turnaround with advent of multiple antibody assays such as antibodies to citrullinated protein/...
Catalog:
Rockville Research
January 2019
Price: USD 1,100.00
Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the...
Catalog:
Grace Market Data
November 2021
Price: USD 2,700.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Cetuximab Biosimilar market will undergo major changes...
Catalog:
Arsta
May 2023
Price: USD 3,600.00
Asia Pacific monoclonal antibodies market will grow by 12.8% annually with a total addressable market cap of $414 billion over 2021-2030 owing to the...
Catalog:
Grace Market Data
December 2021
Price: USD 2,700.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Rituximab Biosimilars market will undergo major changes...
Catalog:
Arsta
September 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Biosimilar Contract Manufacturing market will undergo...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Biosimilar Contract Manufacturing market will undergo...
Catalog:
Arsta
November 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Cetuximab Biosimilar market will undergo major changes...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
Asia Pacific active pharmaceutical ingredients (API) market will grow by 9.1% annually with a total addressable market cap of $584.2 billion over...
Catalog:
Grace Market Data
June 2020
Price: USD 2,480.00
Diabetes has emerged as a major economic burden with high associated human and financial cost. It a chronic disease affecting millions of population...
Catalog:
Rockville Research
March 2017
Price: USD 1,100.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Chemical, Industrial & Pharmaceutical Laboratories, now known as...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
Pharmaceuticals in South Korea Summary Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary...
Catalog:
MarketLine
May 2020
Price: USD 350.00
Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2023
Price: USD 175.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
